Clone
Clone Robotics develops musculoskeletal humanoid robots and robotic hands using proprietary Myofiber synthetic muscle technology, serving individual consumers for home assistance and enterprises in industrial automation, medical, and service robotics applications.
- Company typePrivate
- Founded2014
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Clone does
Clone Robotics (operating as Clone) is a privately held robotics company founded in 2014 in Poland by Łukasz Kozlik, with co-founder and CEO Dhanush Radhakrishnan joining in 2020. The company develops musculoskeletal humanoid robots and robotic components built around its proprietary Myofiber synthetic muscle technology, pioneered in 2021. Its product portfolio centers on the Clone Hand — a biomimetic 24–27 degree-of-freedom robotic hand with patented McKibben hydraulic muscles — and the Clone Alpha, a bipedal android with 206 anatomically accurate bones, over 1,000 Myofiber muscles, and more than 200 degrees of freedom, intended for home assistance and enterprise applications. Supporting technologies include a hydraulic vascular actuation system, the Neural Joint V2 neural-network controller trained on human hand movement footage, NVIDIA Jetson edge compute, and the Telekinesis training platform for in-house skill acquisition.
The company's core differentiator is mechanical rather than algorithmic: soft polymer-based Myofiber fibers reportedly deliver sub-50ms response, over 30% unloaded contraction, and at least 1kg of force from a single 3-gram fiber, with third-party reporting indicating the Clone Hand can be manufactured for approximately $2,800. The product portfolio spans Protoclone V1 (a prototype platform featuring depth cameras, 320 pressure sensors, and 70 joint sensors), Clone Alpha (limited edition of 279 units targeted at home use), and Neoclone (next-generation humanoid in development). Target customers include individual consumers seeking home-automation assistance and enterprises in industrial automation, medical rehabilitation, and service robotics.
Clone operates a direct-to-consumer go-to-market model through clonerobotics.com, with Clone Alpha pre-orders opening in 2025 and full pricing not publicly disclosed. Revenue is generated primarily through one-time hardware sales, with the Telekinesis platform representing a potential professional-services and recurring-revenue layer. The company maintains dual headquarters in Warsaw, Poland and Atherton, California, and is backed by Initialized Capital and Pioneer Fund following an early-stage round in October 2022. As of available data, no revenue has been publicly disclosed and the company remains in pre-commercial stage.
Clone firmographics
Firmographics- Name
- Clone
- Legal name
- Clone Robotics
- Website
- https://clonerobotics.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clone Robotics develops musculoskeletal humanoid robots and robotic hands using proprietary Myofiber synthetic muscle technology, serving individual consumers for home assistance and enterprises in industrial automation, medical, and service robotics applications.
- Ownership category
- akta.pro rank
Clone industry classification
Industry- Product category
- Humanoid Robotics
- akta.pro primary industry
- Humanoid & General-Purpose Robots (HDAAAIAJ)
- akta.pro secondary industries
- Robot Hardware, Actuators & Components (sensors, grippers, motors) (HDAAAIAL), Home Companion & Social Robots (CRACARAE)
Keywords
Where Clone is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Clone business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Clone Alpha Humanoid Robot Sales: One-time hardware sales of the Clone Alpha limited edition humanoid robot, with only 279 units manufactured for the initial production run. Target customers include individuals and businesses for home use.
- Clone Hand Sales: Sale of the Clone Hand robotic component, designed for manipulation tasks. The hand can be used independently or as a component of the Clone Alpha humanoid robot.
- Telekinesis Training Platform: Training platform pre-installed on Clone Alpha allowing users to teach the Clone new skills, potentially representing additional service revenue opportunity.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Clone Alpha Limited Edition |
| Unit Pricing | Pay-as-you-go | Clone Hand |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Clone product offering
Product offeringCore offering
Clone Robotics manufactures musculoskeletal humanoid androids powered by its proprietary Myofiber synthetic muscle technology. Its flagship Clone Alpha is a bipedal android with 206 anatomically accurate bones and over 1,000 artificial myofiber muscles designed for home assistance, while Clone Hand is a standalone 24–27 degree-of-freedom biomimetic robotic manipulator offered as both an independent product and a component of the full android.
Product overview
Clone (Clone Robotics) is a robotics company that develops musculoskeletal, intelligent androids. The product portfolio centers on two main offerings: Clone Hand, a highly biomimetic robotic hand featuring 24-27 degrees of freedom and proprietary Myofiber synthetic muscles capable of human-level precision and strength; and Clone Alpha, a bipedal humanoid android with 206 bones and over 1,000 synthetic muscles designed for home assistance. The company also developed Protoclone V1 as a prototype predecessor and is working on Neoclone as the next generation. All products leverage the proprietary Myofiber artificial muscle technology pioneered in 2021, which enables rapid, powerful contraction similar to mammalian skeletal muscle. The Neural Joint V2 Controller enables neural network-based teleoperation, while the Telekinesis Training Platform allows users to teach Clone Alpha new skills. Target markets span industrial automation, medical assistance, and service robotics applications.
Differentiator
Problem solved
Functional benefit
Brands
- Clone Hand: Human-level robotic hand with 24-27 degrees of freedom, featuring Myofiber synthetic muscles and human-level grip strength. The most biomimetic hand ever created.
- Clone Alpha
- Protoclone V1
- Neoclone
- Myofiber
Products and services
- Clone Alpha Bipedal musculoskeletal android with 206 anatomically accurate bones, over 1,000 synthetic myofiber muscles, and over 200 degrees of freedom, designed for individuals and businesses; includes natural language interface and Telekinesis training platform.
- Clone Hand Biomimetic robotic hand with 24–27 degrees of freedom, human-level thumbs, surgical precision, and human-compatible grip strength; powered by Myofiber synthetic muscles and McKibben hydraulic actuators with back-drivable antagonistic muscles and tendons.
- Protoclone V1 Lifelike humanoid robot prototype using synthetic muscles, ligaments, and a hydraulic pump system instead of traditional electric motors, with over 200 degrees of freedom controlled by water-filled actuators and NVIDIA Jetson edge compute.
- Neoclone Next-generation humanoid android in development, focused on refining motion and control for Clone's vision of a limitless future for human beings.
- Telekinesis Training Platform Training platform integrated into Clone Alpha that allows users to teach the android new skills through demonstration, enabling customization of robot capabilities over time.
Quantifiable outcome
- Muscle fiber survives over 650,000 test cycles
- +3 more outcomes
Companies that use Clone
Customer profileSegments2 records
Ideal customer profiles2 records
Clone technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature7 records
Clone partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights6 records
Clone competitors and assessment
Company assessmentDirect peers
- Figure AI: Developer of the Figure 01/02 general-purpose bipedal humanoid robot targeting both commercial and eventually home applications. Directly competes with Clone Robotics in the humanoid platform category, though Figure is more capital-rich and industrially focused.
- 1X Technologies: Builds the Neo bipedal humanoid robot explicitly targeted at the home consumer market, making it the closest direct competitor to Clone Alpha. Shares the consumer-home humanoid thesis and is pursuing similar biomimetic/neuro-inspired design philosophy.
- Apptronik: Developer of the Apollo humanoid robot for industrial and commercial applications, with a roadmap toward home use. Competes with Clone in the general-purpose humanoid category and has partnerships with major enterprise customers.
- Agility Robotics: Creator of Digit, a bipedal humanoid robot focused on logistics and warehouse applications. A direct peer in bipedal humanoid robotics with a deployed fleet at Amazon and other logistics customers.
- Sanctuary AI: Develops Phoenix, a general-purpose humanoid robot with a focus on dexterous manipulation and AI-driven autonomy. Comparable to Clone in combining biomimetic design ambitions with a software/AI platform layer.
- Unitree Robotics: Chinese humanoid and quadruped robotics manufacturer offering the H1 and G1 bipedal humanoids at significantly lower price points. Most direct cost-comparable peer and represents the emerging low-cost competitive threat to premium entrants like Clone.
Broad incumbents
- Tesla (Optimus): Tesla's Optimus humanoid program is explicitly named by Clone as a direct competitor. While Tesla is a broad incumbent across EVs and energy, Optimus represents a well-capitalized humanoid initiative that competes for consumer mindshare and engineering talent.
- Boston Dynamics: Long-established leader in legged and humanoid robotics (Atlas). Also cited by Clone as a competitor. A broad incumbent owned by Hyundai with deep R&D resources and a deployed commercial product (Spot) that validates the legged robotics category.
Emerging players
- Fourier Intelligence: Developer of the GR-1 and GR-2 general-purpose humanoid robots, with a background in rehabilitation robotics. Comparable to Clone through its humanoid platform ambitions and its earlier work in biomimetic rehabilitation devices.
- Agibot: Chinese humanoid robotics startup that has demonstrated bipedal humanoids for both industrial and consumer applications. An emerging competitor with significant Chinese capital backing pursuing a similar general-purpose humanoid thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Clone social profiles
Digital presenceClone financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clone leadership team
Management profileNumber of profiles
Profiles2 records
Clone funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clone M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clone
What does Clone do?
Clone Robotics manufactures musculoskeletal humanoid androids powered by its proprietary Myofiber synthetic muscle technology. Its flagship Clone Alpha is a bipedal android with 206 anatomically accurate bones and over 1,000 artificial myofiber muscles designed for home assistance, while Clone Hand is a standalone 24–27 degree-of-freedom biomimetic robotic manipulator offered as both an independent product and a component of the full android.
Is Clone a public or private company?
Clone is a private company. It is classified as venture growth investor backed and is currently operating.
When was Clone founded?
Clone was founded in 2014. It employs 11 to 50 people.
Where is Clone based?
Clone is headquartered in New York, United States, in the North America region.
How does Clone make money?
Three revenue lines are on record. Clone Alpha Humanoid Robot Sales are the primary driver. The others are clone Hand Sales and telekinesis Training Platform.
Who are Clone's main competitors?
Direct peers on record are Figure AI, 1X Technologies, Apptronik, Agility Robotics, Sanctuary AI and Unitree Robotics. Broad incumbents are Tesla (Optimus) and Boston Dynamics. Emerging players are Fourier Intelligence and Agibot.
Does Clone have an API?
No public API is recorded for Clone.
What industry is Clone in?
Clone's product category is Humanoid Robotics. Its primary akta.pro industry code is HDAAAIAJ, Humanoid & General-Purpose Robots, with a secondary code of HDAAAIAL, Robot Hardware, Actuators & Components (sensors, grippers, motors).